Management of Paroxysmal Atrial Fibrillation with CHA2DS2-VASc Score of 0

Risk Assessment and Anticoagulation Decision

• Patients with a CHA2DS2-VASc score of 0 have a truly low risk of stroke, with an adjusted stroke rate of approximately 0% per year 3, 4
• The American Heart Association, American College of Cardiology, and Heart Rhythm Society guidelines specifically recommend against anticoagulation therapy for patients with a CHA2DS2-VASc score of 0 2

Evidence Supporting No Anticoagulation

• The 2018 CHEST guidelines strongly recommend that "low risk patients are generally those age < 65 and 'lone AF' irrespective of sex (this includes those with a CHA2DS2-VASc score = 0 in males)" and should not be offered antithrombotic therapy 1

Monitoring and Follow-up

• Regular reassessment of thromboembolic risk is recommended at periodic intervals, as risk factors may develop over time 5
• The CHA2DS2-VASc score should be recalculated whenever new risk factors emerge, as this may change the recommendation regarding anticoagulation 2
• Even in patients with a current score of 0, monitoring for the development of hypertension, diabetes, heart failure, or advancing age (≥65 years) is important as these would increase the score and potentially change management recommendations 3, 5

Clinical Pitfalls to Avoid

• Do not use antiplatelet therapy alone for stroke prevention in AF patients regardless of CHA2DS2-VASc score, as this provides minimal stroke protection with similar bleeding risks 1
• Remember that female sex alone (CHA2DS2-VASc score of 1 due solely to female sex) is not an indication for anticoagulation, as these patients are also considered low risk 2
• Avoid confusing paroxysmal AF with other forms of AF when making treatment decisions - the stroke risk in paroxysmal AF is determined by risk factors, not the pattern of arrhythmia 3